查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2009221

不孕症檢測市場規模、佔有率、趨勢和預測：按產品、購買方式、應用、最終用戶和地區分類，2026-2034年

Fertility Test Market Size, Share, Trends, and Forecast by Product, Mode of Purchase, Application, End User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3個工作天內

價格

2025年全球生育力檢測市場規模為6.167億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到10.05億美元，2026年至2034年的複合年成長率（CAGR）為5.30%。北美目前佔據市場主導，預計2025年將佔據38.6%的市場。市場擴張的原因在於人們對生殖健康的日益關注，以及對早期診斷和居家檢測需求的成長。排卵預測試劑、數位設備和行動連線解決方案的技術進步提高了檢測的準確性和便利性。人們對計劃生育的日益重視以及醫療保健服務的普及，持續推動生育力檢測的普及，進一步鞏固了其市場佔有率。

推動這一市場發展的因素眾多，反映了生活方式的改變、醫療保健需求的變化以及技術的進步。肥胖、壓力、久坐不動的生活方式和飲食習慣的改變導致不孕不育率上升，進而推動了對可靠的不孕症檢測解決方案的需求。卵巢症候群（PCOS）的高發生率（估計影響全球6-13%的育齡女性）也促進了市場成長。大眾對生殖健康和早期不孕症檢測益處的認知不斷提高，尤其推動了家用和商用檢測套組的普及。人工智慧驅動的精液分析、數位不孕症監測儀和整合行動應用程式等技術進步提高了檢測的準確性和便利性。此外，主要企業加大研發投入，加速了創新產品的上市，並提高了消費者取得這些產品的途徑。

美國生育力檢測市場的成長主要受不孕症發病率上升的驅動，而不孕症的上升與壓力、肥胖、缺乏運動和晚婚等生活方式因素密切相關。卵巢症候群（PCOS）是女性不孕症的主要原因之一，其日益普遍的盛行率進一步推動了對可靠檢測方案的需求。人們對生殖健康的日益關注以及市面上家用生育力檢測套組的普及，使得檢測更加便捷。人工智慧驅動的精子分析、數位排卵檢測套組和生育追蹤應用程式等技術進步，提高了檢測的準確性和使用者體驗。此外，美國強大的醫療基礎設施、高額的醫療費用支出以及主要企業的積極研發投入，也促進了創新和應用，從而推動了市場成長。例如，2023年12月，生殖技術Start-UpsOrchid宣布推出先進的基因檢測解決方案，為美國的準父母提供支援。該公司發布了首個商業化的胚胎全基因組定序報告，該報告專為接受體外受精的夫婦開發，旨在解決不孕症和潛在的遺傳風險。

不孕症檢測市場的發展趨勢：

卵巢症候群（PCOS）盛行率和不孕率不斷上升

卵巢症候群（PCOS）等疾病的日益普遍，是推動生育力檢測市場發展的主要動力。 PCOS是由卵巢雌激素分泌過多引起的。根據世界衛生組織（WHO）估計，PCOS影響6%至13%的育齡女性，使其成為女性最常見的內分泌疾病之一。此外，生活方式的改變、壓力、肥胖和不良飲食習慣也導致全球生育率上升。美國國家醫學圖書館報告稱，全球8%至12%的育齡夫婦面臨受孕困難，使得不孕症成為一個重要的公共衛生問題，並增加了對早期、準確的生育力檢測解決方案的需求。

意識的提高和技術的進步

公眾對生育力檢測益處的日益了解正在推動生育力檢測市場的發展趨勢。隨著人們越來越積極主動地關注自身生殖健康，對排卵檢測套組、驗孕棒和生育監測儀的需求也不斷成長。同時，技術先進產品的推出也積極促進了這些產品的普及。各公司紛紛推出配備數位化介面、行動連線和集中式生育治療追蹤功能的設備，以提升使用者體驗。對高精度、易用型監測儀的需求不斷成長，進一步強化了這個趨勢。這些創新不僅使生育力檢測更加便捷，也更加可靠，從而鼓勵更多消費者將這些產品納入其家庭計畫中。例如，2023年8月，Trajan Scientific and Medical公司向德國Start-UpsFertilli提供了其獲得CE-IVD認證的Mitra®設備。 Fertilli推出了歐洲首款家用生育力檢測套組。這些套裝採用VAMS®乾血微量採樣技術，並獲得醫療認證，目前已在歐洲各地上市。

投資、人工智慧整合以及醫療保健市場的成長

主要企業在研發領域的大規模投入正在為生育力檢測市場創造新的機會。各公司致力於創新懷孕和排卵檢測套組，旨在集中收集與生育力相關的數據，並提供全面的分析。此外，人工智慧（AI）在精液分析中的應用正成為一項變革性因素，顯著提升了生育力評估的準確性和效率。例如，2025年8月，香港大學李嘉誠醫學院（HKUMed）的研究人員開發出突破性的人工智慧模型，能夠檢測出具有活性的人類精子。該系統準確率超過96%，展現出卓越的性能。除了這些技術進步之外，全球醫療保健產業的快速發展也推動了相關基礎設施的完善和產品供應的擴展。這些因素不僅共同推動了市場擴張，也為尋求利用創新並滿足全球日益成長的生育力檢測解決方案需求的投資者創造了盈利的回報。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 二手資訊
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球不孕症檢測市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 排卵預測試劑盒
  • 不孕症監測
  • 男性不孕症檢測產品

第7章 市場區隔：依購買方式分類

  • 場外交易基礎
  • 處方箋藥

第8章 市場區隔：依應用領域分類

  • 女性不孕症檢查
  • 男性不孕症檢查

第9章 市場區隔：依最終用戶分類

  • 醫院
  • 居家醫療
  • 不孕症治療診所
  • 其他

第10章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第11章 SWOT 分析

第12章：價值鏈分析

第13章：波特五力分析

第14章：價格分析

第15章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • AdvaCare Pharma
    • Babystart
    • Church & Dwight Co., Inc.
    • ExSeed Health
    • Fairhaven Health
    • LetsGetChecked
    • Medical Electronic Systems
    • Mira Fertility
    • Modern Fertility
    • Proov
    • Quest Consumer Inc
Product Code: SR112026A5810

The global fertility test market size was valued at USD 616.7 Million in 2025. Looking forward, IMARC Group estimates the market to reach USD 1,005.0 Million by 2034, exhibiting a CAGR of 5.30% during 2026-2034. North America currently dominates the market, holding a significant market share of 38.6% in 2025. The market is expanding as awareness about reproductive health rises and demand for early diagnosis and home-based testing grows. Technological advancements in ovulation prediction kits, digital devices, and mobile-connected solutions are enhancing accuracy and convenience. Increasing emphasis on family planning and accessible healthcare services continues to drive adoption, strengthening the fertility test market share.

The market is driven by multiple factors that reflect changing lifestyle patterns, medical needs, and technological progress. Rising infertility rates due to obesity, stress, sedentary lifestyles, and dietary changes have increased demand for reliable fertility testing solutions. The high prevalence of polycystic ovary syndrome (PCOS), which affects an estimated 6-13% of reproductive-aged women globally, further contributes to market growth. Growing public awareness about reproductive health and the benefits of early fertility testing has encouraged adoption, particularly of home-based and over-the-counter kits. Technological advancements, including AI-powered sperm analysis, digital fertility monitors, and connected mobile applications, are enhancing accuracy and convenience. Moreover, increasing investments in research and development (R&D) by key players are fostering innovative product launches and accessibility.

The fertility test market growth in the United States is driven by rising infertility rates linked to lifestyle factors such as stress, obesity, sedentary habits, and delayed parenthood. A growing prevalence of polycystic ovary syndrome (PCOS), one of the leading causes of infertility among women, further fuels demand for reliable testing solutions. Increasing awareness of reproductive health and greater acceptance of home-based, over-the-counter fertility kits have made testing more accessible and convenient. Technological advancements, including AI-enabled sperm analysis, digital ovulation kits, and fertility tracking apps, are improving accuracy and user experience. Strong healthcare infrastructure, coupled with high healthcare expenditure and active research and development (R&D) investments by leading companies, also supports innovation and adoption, strengthening the market growth in the country. For instance, in December 2023, reproductive technology startup Orchid introduced an advanced genetic testing solution aimed at supporting prospective parents across the US. The company unveiled the first commercially available whole genome sequencing report for embryos, specifically developed for couples undergoing in vitro fertilization to address infertility or potential hereditary risks.

FERTILITY TEST MARKET TRENDS:

Rising Prevalence of PCOS and Infertility Rates

The growing prevalence of diseases such as polycystic ovary syndrome (PCOS), caused by the overproduction of estrogen by the ovaries, is a major factor driving the fertility test market. According to the World Health Organization (WHO), PCOS affects an estimated 6-13% of reproductive-aged women, making it one of the most common endocrine disorders among women. Alongside this, infertility rates are rising globally due to lifestyle changes, stress, obesity, and poor dietary patterns. The National Library of Medicine reports that 8%-12% of reproductive-aged couples worldwide experience difficulties conceiving, making infertility a significant public health concern and increasing the demand for early, accurate fertility testing solutions.

Growing Awareness and Technological Advancements

The increasing awareness among the masses about the benefits of fertility testing is boosting the fertility test market trends. Individuals are more proactive about reproductive health, creating greater demand for ovulation kits, pregnancy tests, and fertility monitors. At the same time, the introduction of technologically advanced products is positively influencing adoption. Companies are launching devices with digital interfaces, mobile connectivity, and centralized fertility tracking to improve user experience. The growing demand for easy-to-use monitors with high accuracy further strengthens this trend. These innovations not only make fertility testing more accessible but also enhance reliability, thereby encouraging more consumers to integrate such products into their family planning journeys. For instance, in August 2023, Trajan Scientific and Medical supplied its CE-IVD registered Mitra(R) devices to Fertilly, a German startup that introduced Europe's first at-home fertility testing kits. These kits, which use VAMS(R) technology for dried blood microsampling, are medically certified and now accessible to consumers across Europe.

Investments, AI Integration, and Healthcare Growth

The extensive investment by key players in research and development (R&D) is providing new opportunities in the fertility test market. Companies are innovating pregnancy and ovulation kits designed to centralize fertility-related data and provide comprehensive insights. In addition, the integration of artificial intelligence (AI) in sperm analysis is emerging as a transformative factor, improving accuracy and efficiency in fertility evaluations. For instance, in August 2025, researchers from the Li Ka Shing Faculty of Medicine at the University of Hong Kong (HKUMed) developed a groundbreaking artificial intelligence model capable of detecting human sperm with fertilization potential. The system demonstrated exceptional performance, reaching an accuracy level exceeding 96 percent. Alongside these technological advances, the rapid growth of the global healthcare industry is creating supportive infrastructure and wider product accessibility. Together, these elements are not only driving market expansion but also opening lucrative opportunities for investors seeking to leverage innovation and meet the increasing global demand for fertility testing solutions.

FERTILITY TEST INDUSTRY SEGMENTATION:

Analysis by Product:

  • Ovulation Prediction Kits
  • Fertility Monitors
  • Male Fertility Testing Products

Ovulation prediction kits stand as the largest product in 2025, holding 43.8% of the market due to their widespread accessibility, ease of use, and high accuracy in detecting fertile windows. These kits provide quick results at home, empowering women to track ovulation without clinical intervention, which makes them highly convenient and cost-effective. Rising infertility issues and conditions like polycystic ovary syndrome (PCOS) have further increased reliance on such tools for effective family planning. Growing awareness about reproductive health, coupled with the availability of both digital and traditional test formats, has expanded their adoption globally. Additionally, frequent product innovations with advanced features, including smartphone connectivity and improved sensitivity, continue to strengthen their dominance in the fertility test market.

Analysis by Mode of Purchase:

  • OTC-based
  • Prescription-based

OTC-based leads the market with 68.7% of market share in 2025 because they offer affordability, convenience, and immediate accessibility without requiring medical prescriptions. Consumers increasingly prefer at-home solutions for privacy and ease, especially when tracking ovulation or confirming pregnancy. The availability of a wide range of products, from ovulation prediction kits to digital fertility monitors, in pharmacies, supermarkets, and online platforms further enhances their reach. Growing awareness about reproductive health, coupled with lifestyle-driven fertility challenges, has accelerated their adoption worldwide. Moreover, frequent advancements in accuracy, user-friendly designs, and smartphone connectivity make OTC products more reliable. These factors, combined with rising demand for self-care solutions, solidify OTC-based tests as the leading category in the market.

Analysis by Application:

  • Female Fertility Testing
  • Male Fertility Testing

Female fertility testing leads the market with 83.7% of market share in 2025, as infertility concerns are more commonly addressed in women, with conditions such as polycystic ovary syndrome (PCOS), endometriosis, and hormonal imbalances significantly affecting reproductive health. A wide variety of female-focused fertility products, including ovulation prediction kits, digital monitors, and home-based hormone tests, make access easier and more affordable. Increasing awareness about reproductive health, combined with the rise in infertility rates caused by stress, obesity, and lifestyle changes, has further fueled demand. Continuous innovations and growing acceptance of self-testing strengthen the dominance of female fertility testing in the fertility test market outlook.

Analysis by End User:

  • Hospitals
  • Home Care Settings
  • Fertility Clinics
  • Others

Home care settings lead the market with 55.7% of market share in 2025 due to rising consumer preference for privacy, convenience, and cost-effectiveness. Many individuals and couples opt for at-home fertility tests to avoid frequent clinic visits and to monitor reproductive health discreetly. The availability of accurate and easy-to-use ovulation kits, pregnancy tests, and digital fertility monitors enhances adoption. Growing awareness of reproductive health, coupled with lifestyle-driven infertility challenges, has increased demand for home-based solutions. Additionally, e-commerce platforms and pharmacies provide widespread accessibility to these products, making them highly convenient. According to the fertility test market forecast, technological advancements, such as app-connected devices and AI-enabled monitoring, further improve accuracy and user experience. These factors collectively reinforce the dominance of home care settings in the market.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2025, North America accounted for the largest market share of 38.6%. The fertility test market demand in North America is driven by rising infertility rates linked to lifestyle changes, stress, obesity, and delayed family planning. A growing prevalence of conditions like polycystic ovary syndrome (PCOS) and hormonal disorders also contributes to the demand for advanced fertility solutions. Strong awareness of reproductive health, supported by educational campaigns and healthcare initiatives, encourages early diagnosis and testing. The region benefits from widespread availability of over-the-counter fertility products through pharmacies and online platforms, making them easily accessible. Moreover, technological advancements, including digital ovulation kits, connected fertility monitors, and AI-based sperm analysis, enhance accuracy and adoption. Significant investments in healthcare infrastructure and the strong presence of key market players further accelerate market growth in North America.

KEY REGIONAL TAKEAWAYS:

UNITED STATES FERTILITY TEST MARKET ANALYSIS

In 2025, the United States accounted for 88.50% of the fertility test market in North America. The fertility test market in the United States is witnessing significant growth driven by increasing awareness of reproductive health among individuals across various age groups. Advancements in digital health technologies are enabling the integration of at-home fertility tracking tools with smartphone applications, which enhances user engagement and convenience. The Centers for Disease Control and Prevention (CDC) reports that around 19% of married women aged 15 to 49 without previous births face difficulties conceiving after one year of attempts, while approximately 26% in the same group encounter challenges with becoming pregnant or sustaining a pregnancy to term. This high prevalence of fertility challenges is pushing demand for accurate and accessible fertility monitoring solutions. The expanding availability of personalized testing options tailored to specific hormonal cycles further strengthens consumer preference. Additionally, insurance coverage for diagnostic services and the proliferation of health education platforms are helping normalize fertility discussions. The widespread adoption of e-commerce and direct-to-consumer testing kits is transforming distribution, while innovation in biomarker detection and predictive analytics enhances test reliability. As fertility awareness becomes an integral aspect of health-conscious living, the US market is poised for sustained expansion.

EUROPE FERTILITY TEST MARKET ANALYSIS

The fertility test market in Europe is expanding due to increasing public engagement with preventive health and diagnostic technologies. A growing inclination toward natural family planning methods is driving the use of ovulation and hormone tracking kits as non-invasive alternatives. According to the European Parliamentary Forum on Sexual and Reproductive Rights, 1 in 6 couples in Europe face infertility, equating to approximately 25 million individuals requiring diagnosis and treatment. This significant number of affected individuals is fostering broader acceptance of fertility monitoring tools. Societal shifts, such as an increase in same-sex couples and single-parent families pursuing fertility pathways, are enhancing demand. The integration of fertility assessments into wellness routines, like hormonal balance and menstrual tracking, is expanding the scope of use. Furthermore, strong institutional support for reproductive education in schools and clinics promotes early fertility awareness. Accessibility to over-the-counter test kits, along with normalized fertility discussions via digital media, is creating a more informed consumer base.

ASIA PACIFIC FERTILITY TEST MARKET ANALYSIS

The Asia Pacific fertility test market is benefiting from demographic transitions marked by urbanization and evolving family planning preferences. The United Nations Population Fund (UNFPA) estimates that infertility affects approximately 27.5 million Indian couples, reflecting a pressing need for accessible fertility assessment tools across the region. Rising disposable income is enabling increased spending on personal wellness, including reproductive diagnostics. A significant surge in mobile health adoption supports fertility tracking apps that integrate with home test kits, particularly among younger populations. Shifting social attitudes toward delayed childbearing and smaller families are encouraging the use of fertility tests for proactive planning. Additionally, growing female workforce participation across the region is reinforcing structured health management. Cultural openness to discussing reproductive health, especially in urban centers, is improving visibility and acceptance. Strategic partnerships between diagnostic providers and retail pharmacies are enhancing availability, even in semi-urban regions.

LATIN AMERICA FERTILITY TEST MARKET ANALYSIS

In Latin America, the fertility test market is experiencing growth fueled by rising awareness of reproductive health and a shift toward self-monitoring tools. According to FOLHA DE S.PAULO, Brazil's fertility rate has reached the replacement level of 2.1 children per woman, marking a demographic shift toward smaller families. This change is influencing personal reproductive planning and boosting interest in fertility tracking solutions. Urbanization and growing digital access are driving consumer exploration of non-clinical fertility testing options. Health-focused social media content is playing a crucial role in educating younger generations about fertility cycles. Dual-income households are promoting lifestyle management, fertility tracking, and home diagnostic tools due to improved access, online retail channels, and cultural trends favoring holistic health solutions.

MIDDLE EAST AND AFRICA FERTILITY TEST MARKET ANALYSIS

The fertility test market in the Middle East and Africa is gradually expanding, supported by the region's evolving health and technology landscape. Also, growing women in workforce is helping in driving demand for female-oriented health solutions, including fertility tracking tools. Saudi Vision 2030 reports that as of Q3 2024, the female labor participation rate in Saudi Arabia reached 36%, with women increasingly contributing to biotech and healthcare sectors. Rising smartphone usage and internet access are also enabling the use of fertility-related mobile applications and information platforms. There is growing interest in personalized wellness routines that integrate fertility self-assessment into broader health monitoring. Awareness campaigns and educational initiatives are reducing stigma and encouraging proactive testing, while at-home fertility kits are expanding access in underserved areas, predicting steady growth in adoption.

Competitive Landscape:

The fertility test market is highly competitive, with global and regional players focusing on innovation, product expansion, and technological integration. Key companies emphasize developing advanced ovulation prediction kits, digital fertility monitors, and app-connected devices to meet rising consumer demand for accuracy and convenience. Strategic partnerships, mergers, and acquisitions are common as players aim to expand distribution networks and strengthen global presence. Investments in research and development (R&D) focus on enhancing usability, integrating artificial intelligence in sperm analysis, and centralizing fertility data. Additionally, the growing shift toward home-based and over-the-counter testing drives competition in affordability and accessibility. Companies leveraging e-commerce platforms and digital marketing strategies are gaining a stronger foothold in the rapidly evolving market.

The report provides a comprehensive analysis of the competitive landscape in the global fertility test market with detailed profiles of all major companies, including:

  • AdvaCare Pharma
  • Babystart
  • Church & Dwight Co., Inc.
  • ExSeed Health
  • Fairhaven Health
  • LetsGetChecked
  • Medical Electronic Systems
  • Mira Fertility
  • Modern Fertility
  • Proov
  • Quest Consumer Inc

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the fertility test market?

2. What is the future outlook of the fertility test market?

3. What are the key factors driving the fertility test market?

4. Which region accounts for the largest fertility test market share?

5. Which are the leading companies in the global fertility test market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Fertility Test Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Ovulation Prediction Kits
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Fertility Monitors
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Male Fertility Testing Products
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Mode of Purchase

  • 7.1 OTC-based
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Prescription-based
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Female Fertility Testing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Male Fertility Testing
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Home Care Settings
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Fertility Clinics
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 AdvaCare Pharma
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Babystart
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Church & Dwight Co., Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 ExSeed Health
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Fairhaven Health
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 LetsGetChecked
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Medical Electronic Systems
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Mira Fertility
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Modern Fertility
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Proov
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Quest Consumer Inc
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Fertility Test Market: Major Drivers and Challenges
  • Figure 2: Global: Fertility Test Market: Sales Value (in Million USD), 2020-2025
  • Figure 3: Global: Fertility Test Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 4: Global: Fertility Test Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Fertility Test Market: Breakup by Mode of Purchase (in %), 2025
  • Figure 6: Global: Fertility Test Market: Breakup by Application (in %), 2025
  • Figure 7: Global: Fertility Test Market: Breakup by End User (in %), 2025
  • Figure 8: Global: Fertility Test Market: Breakup by Region (in %), 2025
  • Figure 9: Global: Fertility Test (Ovulation Prediction Kits) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Fertility Test (Ovulation Prediction Kits) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Fertility Test (Fertility Monitors) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Fertility Test (Fertility Monitors) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Fertility Test (Male Fertility Testing Products) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Fertility Test (Male Fertility Testing Products) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Fertility Test (OTC-based) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Fertility Test (OTC-based) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Fertility Test (Prescription-based) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Fertility Test (Prescription-based) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Fertility Test (Female Fertility Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Fertility Test (Female Fertility Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Fertility Test (Male Fertility Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Fertility Test (Male Fertility Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Fertility Test (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Fertility Test (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Fertility Test (Home Care Settings) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Fertility Test (Home Care Settings) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Fertility Test (Fertility Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Fertility Test (Fertility Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Fertility Test (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Fertility Test (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: North America: Fertility Test Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: North America: Fertility Test Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: United States: Fertility Test Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: United States: Fertility Test Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Canada: Fertility Test Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Canada: Fertility Test Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Asia-Pacific: Fertility Test Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Asia-Pacific: Fertility Test Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: China: Fertility Test Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: China: Fertility Test Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Japan: Fertility Test Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Japan: Fertility Test Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: India: Fertility Test Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: India: Fertility Test Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: South Korea: Fertility Test Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: South Korea: Fertility Test Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Australia: Fertility Test Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Australia: Fertility Test Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Indonesia: Fertility Test Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Indonesia: Fertility Test Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Others: Fertility Test Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Others: Fertility Test Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Europe: Fertility Test Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Europe: Fertility Test Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Germany: Fertility Test Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Germany: Fertility Test Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: France: Fertility Test Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: France: Fertility Test Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: United Kingdom: Fertility Test Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: United Kingdom: Fertility Test Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Italy: Fertility Test Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Italy: Fertility Test Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Spain: Fertility Test Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Spain: Fertility Test Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Russia: Fertility Test Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Russia: Fertility Test Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Others: Fertility Test Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Others: Fertility Test Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Latin America: Fertility Test Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Latin America: Fertility Test Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Brazil: Fertility Test Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Brazil: Fertility Test Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Mexico: Fertility Test Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Mexico: Fertility Test Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Others: Fertility Test Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Others: Fertility Test Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Middle East and Africa: Fertility Test Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: Middle East and Africa: Fertility Test Market: Breakup by Country (in %), 2025
  • Figure 79: Middle East and Africa: Fertility Test Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 80: Global: Fertility Test Industry: SWOT Analysis
  • Figure 81: Global: Fertility Test Industry: Value Chain Analysis
  • Figure 82: Global: Fertility Test Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Fertility Test Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Fertility Test Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Fertility Test Market Forecast: Breakup by Mode of Purchase (in Million USD), 2026-2034
  • Table 4: Global: Fertility Test Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 5: Global: Fertility Test Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 6: Global: Fertility Test Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Fertility Test Market: Competitive Structure
  • Table 8: Global: Fertility Test Market: Key Players